Tiefenbacher Group about affordable medicines

Tiefenbacher Group - A pharmacist in a white coat smiles behind a counter. Infographics display bar charts on the European affordable medicines market, highlighting economic value, supply chain, access, and innovation by a family-owned pharmaceutical company.

Why are affordable medicines so important for healthcare?Did you know that affordable (generic) medicines represent the majority of treatments in Europe, accounting for 70% of the treatment volume and 19% of the market value in 2023? They play a crucial role in ensuring patient well-being and public health by providing safe, effective, and affordable treatments. […]

New laboratory and production site for Oncology medicines

Tiefenbacher Group - A modern building with a blue and white geometric facade, large glass windows, and a loading dock where a truck is parked; ideal for API distribution of finished dosage forms, with a partly cloudy sky above.

Did you know that Tiefenbacher Group is in the final phase of constructing a new, state-of-the-art laboratory and production site for highly potent drugs against cancer and other diseases?The new complex is located at Tiefenbacher Laboratories in Hyderabad, India, and covers a total area of approximately 4,000 m². It provides laboratories with the latest equipment […]

Tiefenbacher New Market Launch: generic launch Teriflunomide

Tiefenbacher Group - A smiling woman in a navy raincoat stands on a beach, holding her hood. The AET TIEFENBACHER PHARMACEUTICALS logo appears in the top left, reflecting their focus on patient-centric drug development. The background shows the sea and greenery.

New market launch: Tiefenbacher Pharmaceuticals successfully launches the generic version of Teriflunomide in more than 20 European countriesTiefenbacher Pharmaceuticals has successfully prepared a day one launch of the generic version of the Multiple Sclerosis (MS) medication Teriflunomide (reference brand name: Aubagio). This complex generic launch explicitly follows Tiefenbacher Group`s strategy to make high quality pharmaceuticals […]